We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$161M
AUM Growth
+$11M
(+7.3%)
Cap. Flow
-$5.71M
Cap. Flow
% of AUM
-3.55%
Top 10 Holdings %
Top 10 Hldgs %
44.28%
Holding
361
New
80
Increased
31
Reduced
55
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capri Holdings
CPRI
|
+$1.13M |
| 2 |
Biogen
BIIB
|
+$803K |
| 3 |
AbbVie
ABBV
|
+$773K |
| 4 |
MGM Resorts International
MGM
|
+$610K |
| 5 |
Kearny Financial
KRNY
|
+$521K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1.79M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$1.34M |
| 3 |
GM.WS.B
General Motors Company
GM.WS.B
|
+$1.2M |
| 4 |
CELG
Celgene Corp
CELG
|
+$857K |
| 5 |
TARO
Taro Pharmaceutical Industries Ltd.
TARO
|
+$856K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.05% |
| 2 | Miscellaneous | 33% |
| 3 | Healthcare | 14.28% |
| 4 | Consumer Discretionary | 7.06% |
| 5 | Technology | 5.26% |
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q2 2015 Portfolio in Review
As of Q2 2015, E.E. Geduld held 361 positions worth $161M, up 7.3% from $150M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
E.E. Geduld withdrew a net $5.71M in Q2 2015, closing 58 positions and reducing 55 holdings. Its most notable exit was PHARMACYCLICS INC, an estimated $1.79M position sold in full.
By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 33% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, E.E. Geduld opened a new position in Capri Holdings worth $842K.
- E.E. Geduld's largest Q2 2015 buy was Capri Holdings: 20,000 shares worth $842K.
- E.E. Geduld added most to Blackstone Mortgage Trust in Q2 2015, an estimated $355K increase.
- E.E. Geduld's biggest Q2 2015 reduction was Alnylam Pharmaceuticals, cutting an estimated $1.34M.
- E.E. Geduld fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $1.79M.
- E.E. Geduld's ten largest holdings make up 44% of its $161M portfolio in Q2 2015.
- E.E. Geduld opened 80 new positions and closed 58 in Q2 2015.
- E.E. Geduld's portfolio value rose 7.3% quarter-over-quarter to $161M.
Based on E.E. Geduld's 13F filing for Q2 2015, filed 7 Aug 2015.